Queen’s professor to lead European network on the impact of Covid-19 on cancer treatments

The European Cancer Organisation, the largest multiprofessional cancer organisation in Europe, has announced the establishment of the Special Network to be co-led by Professor Mark Lawler, Associate Pro-Vice-Chancellor and Professor of Digital Health at Queen’s University Belfast and Dr Mirjam Crul, Vice-President of the European Society of Oncology Pharmacy.

The Special Network will amplify the evidence base of the adverse effects of Covid-19 on cancer care across Europe, as well as facilitate agreed recommendations to put to key decision-makers at national and European levels.

Professor Lawler said: “I am exceedingly proud to be invited with my co-chair Professor Mirjam Crul to lead this initiative. Covid-19 does not respect national borders, so it is important that collectively as Europeans we address the universal challenge of ovid-19 and develop sustainable solutions that protect and benefit the European cancer patient.

“This Special Network represents a significant opportunity to stop Cancer becoming the Forgotten C in the battle against Covid-19.”

Professor Stuart Elborn, Pro Vice-Chancellor for the Faculty of Medicine, Health and Life Sciences at Queen’s University, said: “I am delighted that my colleague Professor Mark Lawler has been appointed to lead this extremely important European initiative.

“Professor Lawler’s role in the European Cancer Organisation exemplifies how researchers at Queen’s are key global leaders, helping chart a path through the pandemic.”

The Special Network will build consensus on agreed actions in Europe on how to both undo the current damage from Covid-19.